• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒肽 TAT-I24 对鼠巨细胞病毒病毒基因表达的选择性抑制。

Selective Inhibition of Murine Cytomegalovirus Viral Gene Expression by the Antiviral Peptide TAT-I24.

机构信息

Pivaris BioScience GmbH, 1030 Vienna, Austria.

出版信息

Int J Mol Sci. 2022 Jun 29;23(13):7246. doi: 10.3390/ijms23137246.

DOI:10.3390/ijms23137246
PMID:35806257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267059/
Abstract

The effect of the antiviral peptide TAT-I24 on viral gene expression in cells infected with murine cytomegalovirus (MCMV) was investigated. The expression of immediate-early, early and late genes was highly induced upon infection with MCMV. In the presence of the peptide, the expression of all tested genes was sustainably reduced to a similar extent, independent of whether they were immediate-early, early or late genes. In contrast, the expression of host genes, such as NF-κB inhibitor alpha (), interferon-induced protein with tetratricopeptide repeats 1 (), chemokine (C-X-C motif) ligand 10 (), chemokine (C-C motif) ligand 7 () and chemokine (C-C motif) ligand 5 (), which are induced early upon virus infection, was only transiently suppressed in peptide-treated cells. The expression of other host genes which are affected by MCMV infection and play a role in endoplasmic reticulum stress or DNA-damage repair was not inhibited by the peptide. A combination of TAT-I24 with the nucleoside analogue cidofovir showed enhancement of the antiviral effect, demonstrating that viral replication can be more efficiently inhibited with a combination of drugs acting at different stages of the viral life-cycle.

摘要

研究了抗病毒肽 TAT-I24 对感染鼠巨细胞病毒 (MCMV) 的细胞中病毒基因表达的影响。感染 MCMV 后,立即早期、早期和晚期基因的表达被高度诱导。在肽的存在下,所有测试基因的表达都被持续降低到相似的程度,无论它们是立即早期、早期还是晚期基因。相比之下,宿主基因的表达,如 NF-κB 抑制剂 alpha ()、干扰素诱导的具有四肽重复的蛋白 1 ()、趋化因子 (C-X-C 基序) 配体 10 ()、趋化因子 (C-C 基序) 配体 7 () 和趋化因子 (C-C 基序) 配体 5 (),这些基因在病毒感染后早期被诱导,仅在肽处理的细胞中被短暂抑制。其他受 MCMV 感染影响并在内质网应激或 DNA 损伤修复中发挥作用的宿主基因的表达不受肽的抑制。TAT-I24 与核苷类似物更昔洛韦的联合使用增强了抗病毒作用,表明通过作用于病毒生命周期不同阶段的药物联合使用可以更有效地抑制病毒复制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/422f899d37bb/ijms-23-07246-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/f312c870742f/ijms-23-07246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/050a12512597/ijms-23-07246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/91480aea3c5e/ijms-23-07246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/b04fdcb8cc6b/ijms-23-07246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/69c99123fc21/ijms-23-07246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/48e01d7e1032/ijms-23-07246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/efb507eec870/ijms-23-07246-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/422f899d37bb/ijms-23-07246-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/f312c870742f/ijms-23-07246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/050a12512597/ijms-23-07246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/91480aea3c5e/ijms-23-07246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/b04fdcb8cc6b/ijms-23-07246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/69c99123fc21/ijms-23-07246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/48e01d7e1032/ijms-23-07246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/efb507eec870/ijms-23-07246-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/713d/9267059/422f899d37bb/ijms-23-07246-g008.jpg

相似文献

1
Selective Inhibition of Murine Cytomegalovirus Viral Gene Expression by the Antiviral Peptide TAT-I24.抗病毒肽 TAT-I24 对鼠巨细胞病毒病毒基因表达的选择性抑制。
Int J Mol Sci. 2022 Jun 29;23(13):7246. doi: 10.3390/ijms23137246.
2
Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.对抗病毒药物耐药的鼠巨细胞病毒具有与人类巨细胞病毒相关的遗传学特征。
J Gen Virol. 2005 Aug;86(Pt 8):2141-2151. doi: 10.1099/vir.0.80910-0.
3
In Vitro Profiling of the Antiviral Peptide TAT-I24.体外鉴定抗病毒肽 TAT-I24。
Int J Mol Sci. 2024 Sep 28;25(19):10463. doi: 10.3390/ijms251910463.
4
Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.鼠巨细胞病毒在分化巨噬细胞中的复制作为病毒发病机制的一个决定因素。
J Virol. 1999 Jul;73(7):5970-80. doi: 10.1128/JVI.73.7.5970-5980.1999.
5
Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of Screenings.抗巨细胞病毒肽为巨细胞病毒进入机制提供了新的见解和筛查的局限性。
mSphere. 2019 Feb 13;4(1):e00586-18. doi: 10.1128/mSphere.00586-18.
6
Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection.操纵病毒微小RNA作为治疗巨细胞病毒感染的潜在抗病毒策略
Viruses. 2017 May 19;9(5):118. doi: 10.3390/v9050118.
7
The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.鼠巨细胞病毒假定的自然杀伤细胞诱饵早期基因m04(gp34)编码一种可被具有保护性的抗病毒CD8 T细胞识别的抗原肽。
J Virol. 2000 Feb;74(4):1871-84. doi: 10.1128/jvi.74.4.1871-1884.2000.
8
Functional Comparison of Molluscum Contagiosum Virus vFLIP MC159 with Murine Cytomegalovirus M36/vICA and M45/vIRA Proteins.传染性软疣病毒vFLIP MC159与鼠巨细胞病毒M36/vICA和M45/vIRA蛋白的功能比较
J Virol. 2015 Dec 30;90(6):2895-905. doi: 10.1128/JVI.02729-15.
9
Murine Cytomegalovirus Protein pM49 Interacts with pM95 and Is Critical for Viral Late Gene Expression.鼠巨细胞病毒蛋白 pM49 与 pM95 相互作用,对病毒晚期基因表达至关重要。
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01956-19.
10
Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).用编码鼠巨细胞病毒M84(人巨细胞病毒pp65的同源物)的DNA疫苗抑制鼠巨细胞病毒(MCMV)复制。
J Virol. 2000 Apr;74(8):3696-708. doi: 10.1128/jvi.74.8.3696-3708.2000.

引用本文的文献

1
Harnessing Antiviral Peptides: From Molecular Mechanisms to Clinical Translation.利用抗病毒肽:从分子机制到临床转化
Curr Res Pharmacol Drug Discov. 2025 Jul 15;9:100228. doi: 10.1016/j.crphar.2025.100228. eCollection 2025.
2
The Virus Entry Pathway Determines Sensitivity to the Antiviral Peptide TAT-I24.病毒进入途径决定了对抗病毒肽TAT-I24的敏感性。
Viruses. 2025 Mar 23;17(4):458. doi: 10.3390/v17040458.
3
In Vitro Profiling of the Antiviral Peptide TAT-I24.体外鉴定抗病毒肽 TAT-I24。

本文引用的文献

1
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.广谱抗病毒策略和核苷类似物。
Viruses. 2021 Apr 13;13(4):667. doi: 10.3390/v13040667.
2
A review: Mechanism of action of antiviral drugs.综述:抗病毒药物的作用机制。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211002621. doi: 10.1177/20587384211002621.
3
Antiviral drug discovery: preparing for the next pandemic.抗病毒药物的发现:为下一次大流行做准备。
Int J Mol Sci. 2024 Sep 28;25(19):10463. doi: 10.3390/ijms251910463.
Chem Soc Rev. 2021 Mar 21;50(6):3647-3655. doi: 10.1039/d0cs01118e. Epub 2021 Feb 1.
4
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs.抗击病毒感染的趋势和策略:FDA 批准的抗病毒药物综述。
Int J Biol Macromol. 2021 Mar 1;172:524-541. doi: 10.1016/j.ijbiomac.2021.01.076. Epub 2021 Jan 14.
5
A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication.一种新型的、具有广泛作用的双链DNA病毒基因表达和复制的肽抑制剂。
Front Microbiol. 2020 Nov 17;11:601555. doi: 10.3389/fmicb.2020.601555. eCollection 2020.
6
A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals.从 COVID-19 大流行中吸取的惨痛教训:需要广谱、宿主导向的抗病毒药物。
J Transl Med. 2020 Oct 15;18(1):390. doi: 10.1186/s12967-020-02476-9.
7
Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories.有效灭活血清样本中的尼帕病毒,以确保在低生物安全实验室中安全处理。
Virol J. 2020 Oct 9;17(1):151. doi: 10.1186/s12985-020-01425-8.
8
Antiviral Peptides: Identification and Validation.抗病毒肽:鉴定与验证
Int J Pept Res Ther. 2021;27(1):149-168. doi: 10.1007/s10989-020-10072-0. Epub 2020 May 18.
9
SynergyFinder 2.0: visual analytics of multi-drug combination synergies.SynergyFinder 2.0:多药物组合协同作用的可视化分析。
Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493. doi: 10.1093/nar/gkaa216.
10
Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.早期研究:通过靶向主要即刻早期基因表达或蛋白功能抑制人巨细胞病毒。
Viruses. 2020 Jan 16;12(1):110. doi: 10.3390/v12010110.